In addition to conventional GLP-1 agonists like Ozempic and Wegovy, which only target the GLP-1 receptor, she is also researching medications like Mounjaro, which also targets the GIP receptor, and even the just-released retatrutide, which targets the glucagon receptor in addition to GLP-1 and GIP receptors
This article examines the theoretical mechanisms, reviews available clinical data, and clarifies why GLP-1 agonists are not recommended for rheumatoid arthritis treatment
Results: Over the 11-year study period, 405 LT for SLD were performed at our center: 126 (31%) ALD, 114 (28%) AH, 137 (34%) MASLD, and 28 (7%) MetALD
GLP-1 receptor agonists enhance beneficial bacterial strains, including Bifidobacterium and Lactobacillus, while diminishing harmful species such as Clostridium and Enterobacteriaceae (Singh et al